HPLC vs Mass Spectrometry in Peptide Testing: What Each Method Proves

When a supplier attaches a certificate of analysis to a research peptide, that document almost always rests on two distinct instruments. Understanding HPLC vs mass spectrometry peptide testing is the difference between reading a COA as a marketing artifact and reading it as evidence. The two techniques are frequently named in the same sentence and treated as interchangeable proof of "quality," but they answer separate questions, and a report that leans on one without the other leaves a specific, knowable gap.

This article sets out what each method measures, where each is blind, and why a complete peptide COA generally needs both.

What HPLC actually measures

High-performance liquid chromatography (HPLC) separates the components of a sample by pushing it through a column under pressure. Different molecules travel through the column at different rates, emerge at different times, and are registered by a detector — most commonly a UV detector — as a series of peaks. The area under each peak, expressed as a percentage of total detected area, is what most reports call "purity."

That definition carries two consequences researchers should hold onto:

• HPLC purity is a ratio, not a mass. A 99% area figure describes the composition of the UV-absorbing material in the vial. It says nothing about how much peptide is actually present. A vial can be 99% pure and still be underfilled relative to its labelled quantity.
• HPLC sees what the detector sees. A UV detector responds to species that absorb at the chosen wavelength. Salts, residual water, and certain counter-ions absorb weakly or not at all, so they can be substantially underrepresented in the peak areas. Purity by area-percent is therefore a statement about detectable organic components, not about everything in the vial.

HPLC is the right tool for asking how clean a preparation is relative to related impurities — truncated sequences, deletion products, and other close chromatographic neighbours. It is not, on its own, a tool for confirming what the main peak is.

What mass spectrometry actually measures

Mass spectrometry (MS), usually run downstream of a separation step as LC-MS, measures the mass-to-charge ratio of ionised molecules. For a peptide, the observed mass can be compared against the theoretical mass calculated from the amino acid sequence. When the measured value matches the expected value within instrument tolerance, that is strong evidence the molecule present is the one named on the label.

Mass spectrometry answers the identity question that HPLC cannot: is this actually the compound it claims to be, rather than a different peptide of similar retention behaviour? For a compound like BPC-157 10mg or TB-500 10mg, a matching mass confirms the sequence assembled to the intended target rather than a near-miss.

What MS does not do well on its own is quantify. A confirmed identity tells you the right molecule is present; it does not tell you what proportion of the sample it represents, nor how much sits in the vial.

Why the two are complementary, not redundant

The cleanest way to see the relationship is to line up the questions side by side.

Read together, HPLC and MS establish that a preparation is both clean and correctly identified. Read in isolation, each leaves an opening. A high HPLC figure with no identity confirmation could describe a pure sample of the wrong molecule. An MS match with no purity data confirms the right molecule is present but says nothing about the impurity load surrounding it. Neither, on its own, reports quantity — that requires a dedicated content assay, which is a third measurement entirely.

What this means when you read a COA

When evaluating a certificate, the practical checks follow directly:

1. Confirm the report includes both an HPLC purity chromatogram and a mass spectrometry identity result, not one standing in for the other.
2. Check whether a separate quantity determination is present. Purity and identity together still do not confirm the vial holds the labelled fill.
3. Match the lot number on the report to the lot number on the vial you received. A method is only as useful as its traceability to your specific batch.
4. Verify the document at the issuing laboratory rather than trusting a hosted image. Our approach to independent verification is covered in Janoshik Analytical Explained.

Hermetica Research Labs publishes the third-party HPLC and mass spectrometry certificates tied to each production lot on our COA page, including reports from Janoshik Analytical and Freedom Diagnostics, so the lot number on a vial of Epitalon 10mg or any other item in the catalogue can be matched to the specific document that describes it — both the purity chromatogram and the identity confirmation.

A supplier that shows one method but not the other has answered half the question. Knowing which half is missing is the point.

Research use only. All materials described here are supplied strictly for in-vitro laboratory research and analytical use. They are not drugs, foods, cosmetics, or medical devices, are not approved by Health Canada for any therapeutic purpose, and are not intended for human or veterinary consumption or administration. Nothing in this article constitutes medical, clinical, or regulatory advice.

Both analyses appear on the certificates we publish, which is why we post the underlying reports rather than a purity figure. The full set is in the COA library; see BPC-157 or GHK-Cu for lot-matched examples.